Shaping the Future of Microbial Development: From Gene to GMP

Home | Shaping the Future of Microbial Development: From Gene to GMP

Discover new approaches to shorten development timelines and de-risk scale up.

Speed and scalability now define success in microbial bioprocessing. Join us to explore proven approaches that shorten development timelines and reduce scale-up risk—from early development through GMP. See how platforms like PavewayPLUS™ and ShunzymeX™ streamline development, and how FUJIFILM Biotechnologies’ 30+ years of experience in expressing, purifying and formulating soluble and insoluble biologics with and without conjugation / PEGylation enables rapid, confident progression to GMP with robust, scalable, commercially viable processes.

In this webinar, you will learn:

  • Practical methods to accelerate the journey from gene to GMP without compromising quality

  • Strategies to navigate common challenges in PEGylated and conjugated therapy development

  • How FUJIFILM Biotechnologies can help you formulate and perform drug product clinical mimic studies so you understand the shelf life and stressors of DP filling on your therapy

Primary Interest(Required)
Segments(Required)
Sub-Segments(Required)
Privacy Policy(Required)
By submitting this form I agree that FUJIFILM Biotechnologies may process my data in the manner described in FUJIFILM’s Privacy Policy